Page 41 - Michael Erman News Today

Senator Bernie Sanders sent Moderna a letter asking the drug company to halt planned US price increases on its COVID vaccine, saying price hikes could make the shot unaffordable for millions of Americans.

NEW YORK (Reuters) - Pfizer Inc Chief Executive Albert Bourla said on Monday that the company is not in talks with Chinese authorities to license a ge...

Pfizer Inc is not in talks with Chinese authorities to license a generic version of its COVID-19 treatment Paxlovid for use there, but is in discussions about a price for the branded product, CEO Albert Bourla said.

By Michael Erman (Reuters) - U.S. Senator Bernie Sanders sent Moderna Inc a letter this week asking the drug company to halt planned U.S. price increa...

Sen. Bernie Sanders has asked drug company Moderna to halt a planned U.S. price increases on its COVID shot, saying it could become unaffordable for millions of Americans.

China is in talks with Pfizer Inc to secure a licence that will allow domestic drugmakers to manufacture and distribute a generic version of the U.S. firms COVID-19 antiviral drug Paxlovid in... | January 6, 2023

By Ahmed Aboulenein, Gabriella Borter and Michael Erman (Reuters) - Pharmacies across the United States are weighing whether to sell mifepristone, a p...

By Julie Zhu and Kevin Huang HONG KONG/BEIJING (Reuters) - China is in talks with Pfizer Inc to secure a licence that will allow domestic drugmakers t...

NEW YORK (Reuters) - Drugmakers including Pfizer Inc, GlaxoSmithKline PLC, Bristol Myers Squibb, AstraZeneca PLC and Sanofi SA plan to raise prices in the United States on more than 350 unique drugs in early January, according to data analyzed by healthcare research firm 3 Axis Advisors.

By Michael Erman and Julie Steenhuysen NEW YORK (Reuters) - Drugmakers including Pfizer Inc, GlaxoSmithKline PLC, Bristol Myers Squibb, AstraZeneca PL...